Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer
暂无分享,去创建一个
Jihye Kim | H. Selby | A. Tan | S. Eckhardt | J. Tentler | T. P. Newton | T. Pitts | J. Arcaroli | W. Messersmith | J. DeGregori | R. Hansen | D. Gustafson | R. Winn | M. Gregory | A. Spreafico | K. McPhillips | M. McManus | Peter J. Klauck | Lindsey N. Micel | A. Tan